Tricida, Inc. is an innovative pre-clinical stage biopharmaceutical company, founded in 2013, and focused on the discovery and development of first-in-class therapeutics for metabolic, renal and cardiovascular disease. Tricida’s lead program is TRC101, a novel treatment for complications of chronic kidney disease (CKD). Tricida is led by an experienced and accomplished management team that has worked together for 10 plus years and has raised >$250 M in venture capital from world-class investors over three companies. This team brings their proven leadership and expertise to address the specific disease profile of chronic kidney disease and related complications. The National Health and Nutrition Examination Surveys (NHANES, 1988-1994 and 1999-2004) estimate that over 26 million adults in the United States have chronic kidney disease, with substantial morbidity and mortality associated with the progressive loss of kidney function. The scientists and clinicians at Tricida aim to provide physicians with new drug treatment options to help control the disease and reduce the number of CKD patients requiring dialysis. Tricida’s shared culture of teamwork, comradery and empowerment is evident in the dedication and focus our employees demonstrate, with a commitment to the ultimate goal of improving and prolonging the lives of people living with CKD. If you share our passion for breaking new ground in the discovery and development of first-in-class therapeutics, and are dedicated to building a company centered on cutting-edge science that delivers new innovations to patients, then we would like to speak with you. We seek talented and high-achieving professionals to join us as we work towards bringing critically needed new therapies to patients.
Company Growth (employees)
Type
Private
HQ
South San Francisco, US
Founded
2013
Size (employees)
32 (est)+4%
Tricida was founded in 2013 and is headquartered in South San Francisco, US

Tricida Office Locations

Tricida has an office in South San Francisco
South San Francisco, US (HQ)
201 7000 Shoreline Ct

Tricida Data and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$99.5 m

Latest funding size

$55 m

Time since last funding

10 months

Investors

Tricida's latest funding round in July 2016 was reported to be $55 m. In total, Tricida has raised $99.5 m

Tricida Company Life and Culture

You may also be interested in